Christopher D.�M. Fletcher
About
In The Last Decade
Christopher D.�M. Fletcher
668 papers receiving 67.9k citations
Hit Papers
Peers
Comparison fields: 5 of 170
- Pulmonary and Respiratory Medicine 41.3k
- Rheumatology 23.7k
- Oncology 20.1k
- Surgery 15.0k
- Gastroenterology 14.4k
Countries citing papers authored by Christopher D.�M. Fletcher
This map shows the geographic impact of Christopher D.�M. Fletcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher D.�M. Fletcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher D.�M. Fletcher more than expected).
Fields of papers citing papers by Christopher D.�M. Fletcher
This network shows the impact of papers produced by Christopher D.�M. Fletcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher D.�M. Fletcher. The network helps show where Christopher D.�M. Fletcher may publish in the future.
Co-authorship network of co-authors of Christopher D.�M. Fletcher
This figure shows the co-authorship network connecting the top 25 collaborators of Christopher D.�M. Fletcher. A scholar is included among the top collaborators of Christopher D.�M. Fletcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher D.�M. Fletcher. Christopher D.�M. Fletcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 8 | |
| 3 | 1 | |
| 4 | 9 | |
| 5 | 5 | |
| 6 | 27 | |
| 7 | 124 | |
| 8 | 80 | |
| 9 | 62 | |
| 10 | 171 | |
| 11 | 53 | |
| 12 | PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies breakdown → | 657 |
| 13 | Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor breakdown → | 564 |
| 14 | PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors breakdown → | 1767 |
| 15 | Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor breakdown → | 1719 |
| 16 | 240 | |
| 17 | Pathology and genetics of tumours of soft tissue and bone breakdown → | 1636 |
| 18 | 5 | |
| 19 | S-100 protein staining in liposarcoma: Its diagnostic utility in the high-grade myxoid (round cell) variant | 15 |
| 20 | Leiomyosarcoma with prominent osteoclast-like giant cells. Analysis of eight cases closely mimicking the so-called giant cell variant of malignant fibrous histiocytoma. | 71 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.